Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immunoprecise Antibodies Ltd (IPA)

Immunoprecise Antibodies Ltd (IPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,420
  • Shares Outstanding, K 26,315
  • Annual Sales, $ 15,550 K
  • Annual Income, $ -19,980 K
  • 60-Month Beta 0.09
  • Price/Sales 2.18
  • Price/Cash Flow N/A
  • Price/Book 0.89
Trade IPA with:

Options Overview Details

View History
  • Implied Volatility 557.75% ( +163.15%)
  • Historical Volatility 77.54%
  • IV Percentile 96%
  • IV Rank 53.88%
  • IV High 1,002.30% on 01/10/24
  • IV Low 38.34% on 06/05/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 31
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 3,419
  • Open Int (30-Day) 3,315

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/24
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1700 +5.98%
on 04/18/24
1.6400 -24.39%
on 03/28/24
-0.1600 (-11.43%)
since 03/18/24
3-Month
1.1700 +5.98%
on 04/18/24
2.6000 -52.31%
on 02/06/24
-0.2200 (-15.07%)
since 01/18/24
52-Week
0.9400 +31.91%
on 12/06/23
4.2200 -70.62%
on 05/12/23
-1.4100 (-53.21%)
since 04/18/23

Most Recent Stories

More News
ImmunoPrecise’s Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with Astellas

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”) an AI-driven biotherapeutic research and technology company today announced a research collaboration...

IPA : 1.2400 (-2.36%)
European Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® Technology

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), the parent company of BioKey and affiliate of BioStrand, announced today that the EPO has issued a “Decision...

IPA : 1.2400 (-2.36%)
ImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated with Poor Prognosis and Survival Rates

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), an AI-driven biotherapeutic research and technology company, is pleased to announce that its wholly...

IPA : 1.2400 (-2.36%)
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Lags Revenue Estimates

ImmunoPrecise Antibodies Ltd. (IPA) delivered earnings and revenue surprises of -16.67% and 6.19%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the...

IPA : 1.2400 (-2.36%)
CNTG : 0.4610 (-3.96%)
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced financial results for third quarter fiscal...

IPA : 1.2400 (-2.36%)
ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio

Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA” or the “Company”), an AI-driven biotherapeutic research and technology company, today announced that Talem Therapeutics...

IPA : 1.2400 (-2.36%)
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, today announced that it will host a conference call to discuss...

IPA : 1.2400 (-2.36%)
Axonics Modulation Technologies (AXNX) Surpasses Q4 Earnings and Revenue Estimates

Axonics (AXNX) delivered earnings and revenue surprises of 104.35% and 0.14%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AXNX : 67.05 (-0.22%)
IPA : 1.2400 (-2.36%)
Syneos Health (SYNH) Tops Q4 Earnings and Revenue Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 4.24% and 5.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 42.98 (+0.02%)
IPA : 1.2400 (-2.36%)
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced financial results for second quarter fiscal...

IPA : 1.2400 (-2.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.

See More

Key Turning Points

3rd Resistance Point 1.4000
2nd Resistance Point 1.3400
1st Resistance Point 1.2900
Last Price 1.2400
1st Support Level 1.1800
2nd Support Level 1.1200
3rd Support Level 1.0700

See More

52-Week High 4.2200
Fibonacci 61.8% 2.9670
Fibonacci 50% 2.5800
Fibonacci 38.2% 2.1930
Last Price 1.2400
52-Week Low 0.9400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar